Thymomas are tumors of the thymus and are benign in around 75% of cases. A quarter of thymomas are malignant – they are divided into malignant thymomas and thymic carcinomas depending on the appearance and degree of differentiation of the diseased cells and their tendency to spread [1,3,4]. At 0.2-1.5% of all human malignancies in German-speaking countries and 1.7/1,000,000 in Europe, they account for a very small proportion.
Autoren
- Dr. med. Hans-Joachim Thiel
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- Colorectal cancer
Is exercise better than medication?
- Itching in primary biliary cholangitis
When the skin becomes agony
- TREATswitzerland Register
Evaluation of system therapies for AD
- Cardiogenic shock - 2025 update
Between standardization, team processes and targeted cycle support
- Collagenoses
Scleroderma – Current recommendations for diagnosis and therapy 2025
- Multiple sclerosis
Avoiding the nocebo trap with natalizumab biosimilars
- COPD and comorbidities
Exacerbation frequency is associated with cardiopulmonary disease burden
- Multiple myeloma